18
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1312L |
[SER140]-PLP(139-151) acetate
[SER140]-PLP(139-151) acetate (122018-58-0 Free base) |
Others | Others |
[SER140]-PLP(139-151) acetate 是来自髓鞘蛋白脂蛋白 (PLP) 的肽片段。 | |||
TP1282 |
PLP (139-151)
PLP 139-151 |
||
PLP (139-151) is amino acid residue residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce relapsing-remitting (RR)-EAE model. | |||
TP1312 |
[SER140]-PLP(139-151)
|
||
[SER140]-PLP(139-151) is a polypeptide fragment of the lipid protein of myelin. | |||
TP1402 |
[SER140]-PLP(139-151) TFA (122018-58-0 free base)
[SER140]-PLP(139-151) TFA |
||
[SER140]-PLP(139-151) (TFA) is a polypeptide fragment of the myelin lipid protein. | |||
T81439 |
PLP (178-191)
|
||
PLP (178-191) 是具有生物活性的肽段,为蛋白脂质蛋白(PLP)中的一部分,范围涵盖氨基酸178至191。在SJL小鼠中,PLP作为免疫显性致脑炎表位,是两个主要致脑炎表位之一。与另一致脑炎肽段PLP(139-151)相比,PLP (178-191)可导致更早的疾病发作时间,尽管在发病率、疾病严重性和组织学特征方面与之不具区分性。 | |||
T81438 |
PLP (180-199)
|
||
PLP (180-199) 是一种具备生物活性的肽段,为髓磷脂蛋白(PLP)中氨基酸 180 至 199 的区域。作为中枢神经系统中含量最高的髓磷脂蛋白,PLP (180-199) 在多发性硬化症(MS)的研究中具有重要应用,MS 为一种以中枢神经系统慢性炎症性脱髓鞘为特征的疾病。 | |||
T64674 | Plp(139-151) trifluoroacetate | ||
Plp(139-151) trifluoroacetate 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64674。 | |||
T83690 |
[Leu144, Arg147]-PLP (139-151) TFA
[Leu144, Arg147] Proteolipid Peptide (139-151),H-His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe-OH |
||
[Leu144,Arg147]-PLP (139-151)是髓鞘脂蛋白(PLP)的一种突变肽段,包含位于144和147位置的色氨酸到亮氨酸以及组氨酸到精氨酸的替换。使用[Leu144, Arg147]-PLP (139-151)(50 µg)乳化于完全弗氏佐剂(CFA)免疫后,能增加小鼠脾脏中的IL-4水平。它在体外抑制Th1细胞激活,但在体内不抑制,其中它诱导调节性T细胞的产生。用[Leu144, Arg147]-PLP (139-151)预免疫可以延迟由脑炎肽PLP (178-191)、髓磷脂少突细胞蛋白(MOG) (92-106)或髓鞘基础蛋白(MBP)在小鼠中诱导的实验性自身免疫性脑炎(EAE)的发病。 | |||
T61500 | PLP_Snyder530 | ||
PLP_Snyder530 是一种有效的类木瓜蛋白酶 (PLpro) 抑制剂。PLP_Snyder530 诱导 SARS-COV-2 木瓜蛋白酶样蛋白酶的构象变化,抑制 SARS-COV-2 复制。PLP_Snyder530 可用于 SARS-CoV-2 研究。 | |||
T78704 |
PLpro/RBD-IN-1
|
SARS-CoV | Microbiology/Virology |
PLpro/RBD-IN-1 (化合物 5) 为 SARS-CoV-2 PLpro 与刺突蛋白 RBD (spike protein Receptor Binding Domain) 的双重抑制剂,其 IC50 值分别为7.197 μM 和8.673 μM。 | |||
T12502 |
PLpro inhibitor
5-(乙酰氨基)-2-甲基-N-[(1R)-1-(1-萘基)乙基]苯甲酰胺 |
SARS-CoV | Microbiology/Virology |
PLpro inhibitor 是一种木瓜蛋白酶抑制剂,IC50为 2.6 µM,能抑制 SARS-CoV-2 PLpro。 | |||
T62991 | Mpro/PLpro-IN-1 | ||
Mpro/PLpro-IN-1 (Compound 29) 是一种双重作用的 SARS-CoV-2 蛋白酶抑制剂。Mpro/PLpro-IN-1 也是一种 Mpro/PLpro 的有效抑制剂,对 M pro 具有微摩尔抑制作用(IC50:1.72 μM),对 PL pro 具有亚微摩尔抑制作用(IC50:0.67 μM)。 | |||
T3578L |
Pyridoxal calcium phosphate
|
||
Pyridoxal phosphate (PLP, pyridoxal 5'-phosphate, P5P), known as an active form of vitamin B6, is a coenzyme involved in many enzymatic reactions. | |||
T29033 |
U-7524
2-Aminooxyacetic acid,U 7524,Aminooxyacetic acid,U7524,AOAA |
||
U-7524, also known as AOAA and Aminooxyacetic acid, is an inhibitor of 4-aminobutyrate aminotransferase (GABA-T). AOAA is also a general inhibitor of pyridoxal phosphate (PLP)-dependent enzymes (this includes GABA-T). It functions as an inhibitor by attac | |||
T82020 |
J5 peptide
Myelin basic protein (85-99) antagonist |
||
J5 peptide是MBP抑制剂,竞争性阻断MBP85-99与HLA-DR2的结合。该肽段能减轻PLP139-151/MBP85-99诱导的小鼠实验性自身免疫性脑脊髓炎(EAE)。J5 peptide主要用于研究炎症和免疫疾病。 | |||
T73614 | Tyrosine decarboxylase | ||
Tyrosine decarboxylase (TDC; TyrDC),即酪氨酸脱羧酶,广泛存在于植物、昆虫和不同微生物中,常用于生化研究。Tyrosine decarboxylase 是一种5'-磷酸吡哆醛 (PLP) 依赖性脱羧酶,可以催化酪氨酸中羧基的去除,产生酪胺和二氧化碳。 | |||
T79929 |
L-Methionine γ-lyase
Methionine lyase |
||
L-Methionine γ-lyase(Methionine lyase)是一种依赖磷酸吡哆醛的多功能酶,专门催化L-蛋氨酸(L-methionine)及其类似物的α, γ-裂解反应。该酶因其抗癌和抗感染活性被用于相关疾病的研究,同时也适用于同型半胱氨酸血症研究领域。 | |||
T71174 |
PBT434 HBr
|
||
PBT434 is a novel, brain-penetrant, small molecule inhibitor of α-synuclein aggregation. In transgenic animal models of Parkinson disease (A53T) and MSA (PLP-α-Syn), PBT434 reduced α-synuclein aggregation, preserved neurons and improved motor function. Glial cell inclusions were also reduced in a murine MSA model. PBT434 is thought to act by redistributing reactive iron across membranes, thereby blocking intracellular protein aggregation and oxidative stress. The affinity of PBT434 for iron is g... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3578 |
Pyridoxal phosphate
PLP,PAL-P,磷酸吡哆醛,pyridoxal 5'-phosphate,Pyridoxyl phosphate,Pyridoxal 5′-phosphate,Vitamin B6 phosphate |
Reverse Transcriptase; Endogenous Metabolite | Metabolism; Microbiology/Virology |
Pyridoxal phosphate (Vitamin B6 phosphate) 是维生素 B6 的活性形式,可抑制逆转录酶活性,用于研究迟发性运动障碍症。 | |||
T5085 |
Pyridoxal 5'-phosphate hydrate
Codecarboxylase,Pyridoxal 5'-phosphate hydrate(1:x),5-磷酸吡多醛水合物,PLP,Pyridoxal 5'-phosphate hydrate |
Others; Endogenous Metabolite | Metabolism; Others |
Pyridoxal 5'-phosphate hydrate (PLP) 是内源性代谢产物的一种。 | |||
T8083 |
Pyridoxal 5'-phosphate monohydrate
Pyridoxal phosphate monohydrate,Pyridoxal 5-phosphate monohydrate,5-磷酸吡哆醛 |
Others | Others |
Pyridoxal 5'-phosphate monohydrate 是维生素 B6的活性形式,也是多种酶的重要辅因子。它是维生素 B6 在细胞内磷酸化过程中重要的辅酶变异体,能够与其他变异体(如 PNP 、 PMP)发生互换。 |